361 Capital’s Innoviva INVA Stock Holding History

361 Capital’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$868K	Sell	62,074 -9,657	-13%	-$131K	0.41%	82
2020 Q1	$844K	Buy	+71,731	New	+$949K	0.38%	84
2018 Q2	–	Sell	-92,065	Closed	-$1.53M	–	353
2018 Q1	$1.53M	Sell	92,065 -14,944	-14%	-$231K	0.38%	101
2017 Q4	$1.52M	Sell	107,009 -55,257	-34%	-$737K	0.38%	137
2017 Q3	$2.29M	Buy	+162,266	New	+$2.15M	0.44%	86

Other funds holding INVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

361 Capital's INVA Position: Q2 2020 in Review

361 Capital reduced its Innoviva (INVA) stake by 13% in Q2 2020, selling an estimated $131K and leaving 62,074 shares worth $868K. The position accounts for 0.41% of the portfolio, ranked #82.

361 Capital first reported a position in INVA in Q3 2017 and has held it in 5 quarters since. The position peaked at $2.29M in Q3 2017. 203 funds tracked by Wall St. Rank hold INVA as of Q2 2020.

361 Capital held 62,074 shares of Innoviva worth $868K as of Q2 2020.
361 Capital sold 9,657 Innoviva shares in Q2 2020, an estimated $131K.
Innoviva made up 0.41% of 361 Capital's portfolio in Q2 2020, its #82 holding.
361 Capital first reported a position in Innoviva in Q3 2017 and has held it in 5 quarters since.
361 Capital's Innoviva position peaked at $2.29M in Q3 2017.
203 funds tracked by Wall St. Rank held Innoviva as of Q2 2020.

Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.